Company: HRTX
Filing Date: 2025-02-20
Form Type: 8-K
Source: 0000950170-25-023958
Chunk: 1

Company: HERON THERAPEUTICS, INC. /DE/
Filing Date: 2025-02-20
Form: 8-K
Item: Item 9.01
Chunk 1
---
Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

  Exhibit No.      Description                                                                                                                                                                                           
         10.1      First Amendment to Working Capital Facility Agreement, dated as of February 13, 2025, by and among the Company, the several banks and other financial institutions or entities from time to time ...  
 ─────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
          104      Cover Page Interactive Data File (embedded within the Inline XBRL document).                                                                                                                          

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

                               Heron Therapeutics, Inc.                           
  Date: February 20, 2025      /s/ Ira Duarte                                     
                               Ira Duarte